Pharsight

Slayback Pharma Llc patents expiration

1. Testosterone Cypionate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11642355 SLAYBACK PHARMA LLC Pharmaceutical compositions of testosterone
Mar, 2039

(14 years from now)

US11311554 SLAYBACK PHARMA LLC Pharmaceutical compositions of testosterone
Mar, 2039

(14 years from now)

Drugs and Companies using TESTOSTERONE CYPIONATE ingredient

Market Authorisation Date: 02 June, 2022

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR

More Information on Dosage

TESTOSTERONE CYPIONATE family patents

Family Patents

2. Vivimusta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11844784 SLAYBACK PHARMA LLC Stable pharmaceutical compositions of bendamustine
Jul, 2042

(18 years from now)

Drugs and Companies using BENDAMUSTINE HYDROCHLORIDE ingredient

Market Authorisation Date: 07 December, 2022

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

VIVIMUSTA family patents

Family Patents